Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Institutional National Research Service Award (T32)
Project #
5T32HL007029-24
Application #
2775433
Study Section
Research Training Review Committee (RTR)
Project Start
1975-07-01
Project End
2000-06-30
Budget Start
1998-07-01
Budget End
1999-06-30
Support Year
24
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Weill Medical College of Cornell University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
201373169
City
New York
State
NY
Country
United States
Zip Code
10065
Frieda, S; Pearce, A; Wu, J et al. (1995) Recombinant GST/CD36 fusion proteins define a thrombospondin binding domain. Evidence for a single calcium-dependent binding site on CD36. J Biol Chem 270:2981-6
Allen, S L; Coleman, M (1990) Aggressive phase multiple myeloma: a terminal anaplastic transformation resembling high-grade lymphoma. Cancer Invest 8:417-24
Silverstein, R L; Friedlander Jr, R J; Nicholas, R L et al. (1988) Binding of Lys-plasminogen to monocytes/macrophages. J Clin Invest 82:1948-55
Boyd, D B; Coleman, M; Papish, S W et al. (1988) COPBLAM III: infusional combination chemotherapy for diffuse large-cell lymphoma. J Clin Oncol 6:425-33
Hajjar, D P; Boyd, D B; Harpel, P C et al. (1987) Histidine-rich glycoprotein inhibits the antiproliferative effect of heparin on smooth muscle cells. J Exp Med 165:908-13
Lewis, M J; Oelbaum, M H; Coleman, M et al. (1986) An association between chronic neutrophilic leukaemia and multiple myeloma with a study of cobalamin-binding proteins. Br J Haematol 63:173-80
Arrick, B A; Griffo, W; Cohn, Z et al. (1985) Hydrogen peroxide from cellular metabolism of cystine. A requirement for lysis of murine tumor cells by vernolepin, a glutathione-depleting antineoplastic. J Clin Invest 76:567-74
Allen, S L; Coleman, M (1985) Terminal-phase chronic myelogenous leukemia: approaches to treatment. Cancer Invest 3:491-503
King, M E; Micha, J P; Allen, S L et al. (1985) Immature teratoma of the ovary with predominant malignant retinal anlage component. A parthenogenically derived tumor. Am J Surg Pathol 9:221-31